Literature DB >> 24247270

MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer.

Cailian Zhang1, Shengli Ge, Cailian Hu, Ning Yang, Jinran Zhang.   

Abstract

MicroRNAs (miRNAs) function as negative regulators of gene expression involved in cancer metastasis. The aim of this study is to investigate the potential roles of miR-218 in non-small cell lung cancer and validate its regulation mechanism. Functional studies showed that miR-218 overexpression inhibited cell migration and invasion, but had no effect on cell viability. Enhanced green fluorescent protein reporter assay, real-time polymerase chain reaction and western blot analysis confirmed that miR-218 suppressed the expression of high mobility group box-1 (HMGB1) by directly targeting its 3'-untranslated region. Accordingly, silencing of HMGB1 accorded with the effects of miR-218 on cell migration and invasion, and overexpression of HMGB1 can restore cell migration and invasion which were reduced by miR-218. In conclusion, these findings demonstrate that miR-218 functions as a tumor suppressor in lung cancer. Furthermore, miR-218 may act as a potential therapeutic biomarker for metastatic lung cancer patients.

Entities:  

Keywords:  HMGB1; miR-218; microRNA; non-small lung cancer

Mesh:

Substances:

Year:  2013        PMID: 24247270     DOI: 10.1093/abbs/gmt109

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  35 in total

1.  Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.

Authors:  Ruiguang Zhang; Yan Li; Zhongliang Wang; Lingjuan Chen; Xiaorong Dong; Xiu Nie
Journal:  Tumour Biol       Date:  2015-06-04

2.  miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy.

Authors:  Shibing Guo; Rui Bai; Wanlin Liu; Aiqing Zhao; Zhenqun Zhao; Yuxin Wang; Yong Wang; Wei Zhao; Wenxuan Wang
Journal:  Tumour Biol       Date:  2014-04-22

3.  MicroRNA-218 modulates activities of glioma cells by targeting HMGB1.

Authors:  Jianjun Gu; Rong Xu; Yaxing Li; Jianhe Zhang; Shousen Wang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

4.  MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.

Authors:  Ke Liu; Jun Huang; Jiangdong Ni; Deye Song; Muliang Ding; Junjie Wang; Xianzhe Huang; Wenzhao Li
Journal:  Cell Cycle       Date:  2017-02-10       Impact factor: 4.534

5.  Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.

Authors:  Abeer A Alsofyani; Rawiah A Alsiary; Alaa Samkari; Baraa T Alhaj-Hussain; Jalaluddin Azam Khan; Jaudah Al-Maghrabi; Aisha Elaimi; Mohammed H Al-Qahtani; Adel M Abuzenadah; Ashraf Dallol
Journal:  J Appl Genet       Date:  2017-08-16       Impact factor: 3.240

6.  miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression.

Authors:  Lei Song; Dan Li; Yingkai Zhao; Yue Gu; Dan Zhao; Xiang Li; Xiaoxue Bai; Ying Sun; Xiufang Zhang; Huijie Sun; Yan Wang; Liping Peng
Journal:  Tumour Biol       Date:  2015-09-26

7.  Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin.

Authors:  Qiang Ruan; Zhi-Yuan Fang; Shu-Zhong Cui; Xiang-Liang Zhang; Yin-Bing Wu; Hong-Sheng Tang; Yi-Nuo Tu; Yan Ding
Journal:  Tumour Biol       Date:  2015-02-19

8.  High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer.

Authors:  Feng Wei; Fan Yang; Xiangli Jiang; Wenwen Yu; Xiubao Ren
Journal:  Tumour Biol       Date:  2015-06-26

Review 9.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 10.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.